A
Aardvark Therapeutics, Inc. (AARD)
NMS – Real vaqt narxi. Valyuta: USD
7.01
-0.17 (-2.43%)
Bozor ochiq: Aug 12, 2026, 11:22 AM EDT
7.33
+0.14 (1.95%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
7.01
-0.17 (-2.43%)
Bozor ochiq: Aug 12, 2026, 11:22 AM EDT
7.33
+0.14 (1.95%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Aardvark Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, metabolik kasalliklarni davolash uchun tug'ma gomeostatik yo'llarni faollashtirishga qaratilgan kichik molekulali dorilarni ishlab chiqishga e'tibor qaratadi. Aardvark Therapeutics, Inc. 2017 yilda tashkil etilgan va shtab-kvartirasi San-Diego, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Dvorit Samid Ph.D. | Executive Vice President of Medical Affairs |
| Dr. Manasi Sinha Jaiman M.D., M.P.H. | Chief Medical Officer |
| Dr. Tien-Li Lee M.D. | CEO, Secretary & Chairman |
| Dr. Timothy J. Kieffer Ph.D. | Chief Scientific Officer |
| Dr. Zhenhuan Zheng Ph.D. | Chief Research Officer |
| Mr. Christian Zapf J.D. | General Counsel |
| Mr. Danny Villeneuve | Chief Commercial Officer |
| Mr. Justin T. Stege Ph.D. | VP and Head of Project Management & Strategy |
| Mr. Nelson B. Sun M.B.A. | CFO & COO |
| Mr. Ron Lewis II, Ph.D. | VP & Head of CMC |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-11 | 10-Q | ck0001774857-20260630.htm |
| 2026-07-10 | DEF 14A | ck0001774857-20260710.htm |
| 2026-06-29 | PRE 14A | ck0001774857-20260629.htm |
| 2026-06-12 | 8-K | ck0001774857-20260610.htm |
| 2026-05-14 | 8-K | ck0001774857-20260514.htm |
| 2026-05-07 | 8-K | ck0001774857-20260507.htm |
| 2026-05-07 | 10-Q | ck0001774857-20260331.htm |
| 2026-03-30 | CORRESP | filename1.htm |
| 2026-03-24 | S-8 | ck0001774857-20260323.htm |
| 2026-03-24 | 8-K | ck0001774857-20260323.htm |